Stock Markets

Daily coverage of equity markets, sectors, and major indices.

In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.

Articles

7,592 total articles

Anthropic takes legal fight to court, says government retaliation followed refusal to lift Claude safety limits

Anthropic takes legal fight to court, says government retaliation followed refusal to lift Claude safety limits

Anthropic has filed suit against the U.S. government, saying the administration retaliated after the company refused a Defense Department demand to remove safety restrictions on its Claude model. The company says it modified Claude for classified use, declined to permit deployment for lethal autonomous weapons or mass domestic surveillance, and was…

Markets Jump as Trump Signals Iran Conflict May Be Nearing End

Markets Jump as Trump Signals Iran Conflict May Be Nearing End

U.S. equity benchmarks climbed Monday afternoon after President Trump suggested the U.S.-Iran conflict could be winding down. The remarks, shared in excerpts posted by CBS from an interview on X, included assertions about Iran's diminished military capabilities and a comment that U.S. progress has outpaced his initial 4-5 week estimate. Oil prices …

Anthropic Challenges Pentagon Blacklist Order in Federal Lawsuit

Anthropic Challenges Pentagon Blacklist Order in Federal Lawsuit

On March 9, Anthropic sued the U.S. government, President Donald Trump, Defense Secretary Pete Hegseth and other officials seeking to prevent the Department of Defense from blacklisting the company. The complaint advances claims under the First and Fifth Amendments, argues the presidential directive exceeded legal authority, and contends the DOD’s …

Novo Nordisk, Hims Agree to Sell Branded Wegovy and Ozempic on Telehealth Platform, Lawsuit Withdrawn

Novo Nordisk, Hims Agree to Sell Branded Wegovy and Ozempic on Telehealth Platform, Lawsuit Withdrawn

Novo Nordisk and U.S. telehealth provider Hims & Hers Health reached an agreement for Hims to sell branded Wegovy and Ozempic on its platform, resolving a recent legal dispute. The pact requires Hims to stop advertising compounded GLP-1 drugs, to offer approved injectables and the Wegovy pill at Novo’s self-pay prices, and leads Novo to withdraw it…

Apple Pushes Smart-Display Release to September as Siri Upgrade Lags

Apple Pushes Smart-Display Release to September as Siri Upgrade Lags

Apple has delayed the launch of its smart home display, internally designated J490, until about September after repeated setbacks in completing an upgraded version of its Siri voice assistant. The hardware has reportedly been finished for months, but the company is holding the product until the software - a central element of the device's interface…